Induction of immunoglobulin heavy-chain transcription through the transcription factor bright requires TFII-I

Molecular and Cellular Biology

Volumn 26, Issue 12, 2006, Pages 4758-4768

  Rajaiya, Jaya ^a   Nixon, Jamee C ^a   Ayers, Neil ^a   Desgranges, Zana P ^c   Roy, Ananda L ^c   Webb, Carol F ^a,b,d  

^a UNIVERSITY OF OKLAHOMA HEALTH SCIENCES CENTER   (United States)

^b Department of Microbiology and Immunology ^*  (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d OKLAHOMA MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRUTON TYROSINE KINASE; CHICKEN OVALBUMIN UPSTREAM PROMOTER TRANSCRIPTION FACTOR; IMMUNOGLOBULIN HEAVY CHAIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ARID; TRANSCRIPTION FACTOR BRIGHT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE DIFFERENTIATION; CELL LINE; COMPLEX FORMATION; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME SUBSTRATE; GENE LOCUS; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION;

ANIMALS; B-LYMPHOCYTES; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA-BINDING PROTEINS; GENES, IMMUNOGLOBULIN; HUMANS; IMMUNOGLOBULIN HEAVY CHAINS; MICE; MUTATION; ONCOGENES; PROTEIN STRUCTURE, TERTIARY; PROTEIN-TYROSINE KINASES; RNA, MESSENGER; TRANS-ACTIVATORS; TRANSCRIPTION FACTORS, TFII; TRANSCRIPTION, GENETIC;

EID: 33745023808     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.02009-05     Document Type: Article

References (45)

1. Aoki, Y., K. J. Isselbacher, and S. Pillai. 1994. Bruton tyrosine kinase is tyrosine phosphorylated and activated in pre-B lymphocytes and receptor-ligated B cells. Proc. Natl. Acad. Sci. USA 91:10606-10609.
2. Baba, Y., M. Matsushita, Y. Matsuda, J. Inazawa, T. Yamadori, S. Hashimoto. T. Kishimoto, and S. Tsukada. 1999. Assignment of SH3BP5/SA3bp5 encoding Sab, an SH3 domain-binding protein which preferentially associates with Bruton's tyrosine kinase, to human chromosome 1q43 and mouse chromosome 14B by in situ hybridization. Cytogenet. Cell Genet. 87:221-222.
3. Cariappa, A., M. Tang, C. Parng, E. Nebelitskiy, M. Carroll, K. Georgopoulos. and S. Pillai. 2001. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity 14:603-615.
4. Chaplet, M., C. Detry, C. Deroanne, L. W. Fisher, V. Castronovo, and A. Bellahcene. 2004. Zoledronic acid up-regulates bone sialoprotein expression in osteoblastic cells through Rho GTPase inhibition. Biochem. J. 384:591-598.
5. Cheriyath, V., and A. L. Roy. 2000. Alternatively spliced isoforms of TFII-I-complex formation, nuclear translocation, and differential gene regulation. J. Biol. Chem. 275:26300-26308.
6. Cheriyath, V., Z. P. Desgranges, and A. L. Roy. 2002. c-Src-dependent transcriptional activation of TFII-I. J. Biol. Chem. 277:22798-22805.
7. Cheriyath, V., C. D. Novina, and A. L. Roy. 1998. TFII-I regulates Vβ promoter activity through an initiator element. Mol. Cell. Biol. 18:4444-4454.
8. Cheriyath, V., and A. L. Roy. 2001. Structure-function analysis of TFII-1-roles of the N-terminal end, basic region, and I-repeats. J. Biol. Chem. 276:8377-8383.
9. Conley, M. E. 2002. Early defects in B cell development. Curr. Opin. Allergy Clin. Immunol. 2:517-522.
10. Conley, M. E., A. Broides, V. Hernandez-Trujillo, V. Howard, H. Kanegane, T. Miyawaki, and S. A. Shurtleff. 2005. Genetic analysis of patients with defects in early B-cell development. Immunol. Rev. 203:216-234.
11. Du, H., A. L. Roy, and R. G. Roeder. 1993. Human transcription factor USF stimulates transcription through the initiator elements of the HIV-1 and the Ad-ML promoters. EMBO J. 12:501-511.
12. Egloff, A. M., and S. Desiderio. 2001. Identification of phosphorylation sites for Bruton's tyrosine kinase within the transcriptional regulator BAP/TFII-I. J. Biol. Chem. 276:27806-27815.
13. Fruman, D. A., A. B. Satterthwaite, and O. N. Witte. 2000. Xid-like phenotypes: a B cell signalosome takes shape. Immunity 13:1-3.
14. Goebel, P., A. Montalbano, N. Ayers, E. Kompfner, L. Dickinson, C. F. Webb, and A. J. Feeney. 2002. High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes. J. Immunol. 169:2477-2487.
15. Herrscher, R. F., M. H. Kaplan, D. L. Lelsz, C. Das, R. Scheuermann, and P. W. Tucker. 1995. The immunoglobulin heavy-chain matrix-associating regions are bound by Bright: a B cell-specific trans-activator that describes a new DNA-binding protein family. Genes Dev. 9:3067-3082.
16. Hirano, M., Y. Kikuchi, S. Nisitani, A. Yamaguchi, A. Satoh, T. Ito, H. Iba, and K. Takatsu. 2004. Bruton's tyrosine kinase (Btk) enhances transcriptional co-activation activity of BAM11, a Btk-associated molecule of a subunit of SWI/SNF complexes. Int. Immunol. 16:747-757.
17. Hong, M., M. Lin, J. M. Huang, P. Baumeister, S. Hakre, A. L. Roy, and A. S. Lee. 2005. Transcriptional regulation of the Grp78 promoter by endoplasmic reticulum stress: role of TFII-I and its tyrosine phosphorylation. J. Biol. Chem. 280:16821-16828.
18. Humphries, L. A., C. Dangelmaier, K. Sommer, K. Kipp, R. M. Kato, N. Griffith, I. Bakman, C. W. Turk, J. L. Daniel, and D. J. Rawlings. 2004. Tec kinases mediate sustained calcium influx via site-specific tyrosine phosphorylation of the phospholipase C γ Src homology 2-Src homology 3 linker. J. Biol. Chem. 279:37651-37661.
19. Khan, W. N. 2001. Regulation of B lymphocyte development and activation by Bruton's tyrosine kinase. Immunol. Res. 23:147-156.
20. Kikuchi, Y., M. Hirano, M. Seto, and K. Takatsu. 2000. Identification and characterization of a molecule, BAM11, that associates with the pleckstrin homology domain of mouse Btk. Int. Immunol. 12:1397-1408.
21. Kim, D. W., V. Cheriyath, A. L. Roy, and B. H. Cochran. 1998. TFII-I enhances activation of the c-fos promoter through interactions with upstream elements. Mol. Cell. Biol. 18:3310-3320.
22. Kim, D. W., and B. H. Cochran. 2000. Extracellular signal-regulated kinase binds to TFII-I and regulates its activation of the c-fos promoter. Mol. Cell. Biol. 20:1140-1148.
23. Kim, D. W., and B. H. Cochran. 2001. JAK2 activates TFII-I and regulates its interaction with extracellular signal-regulated kinase. Mol. Cell. Biol. 21:3387-3397.
24. Mahajan, S., A. Vassilev, N. Sun, Z. Ozer, C. Mao, and F. M. Uckun. 2001. Transcription factor STAT5A is a substrate of Bruton's tyrosine kinase in B cells. J. Biol. Chem. 276:31216-31228.
25. Maret, D., M. B. Boffa, D. F. Brien, A. E. Nesheim, and A. L. Koschinsky. 2004. Role of mRNA transcript stability in modulation of expression of the gene encoding thrombin activable fibrinolysis inhibitor. J. Thromb. Haemost. 2:1969-1979.
26. Mohamed, A. J., L. Vargas, B. F. Nore, C. M. Backesjo, B. Christensson, and C. I. Smith. 2000. Nucleocytoplasmic shuttling of Bruton's tyrosine kinase. J. Biol. Chem. 275:40614-40619.
27. Nixon, J. C., J. Rajaiya, and C. F. Webb. 2004. Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J. Biol. Chem. 279:52465-52472.
28. Nixon, J. C., J. B. Rajaiya, N. Ayers, S. Evetts, and C. F. Webb. 2004. The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell. Immunol. 228:42-53.
29. Novina, C. D., S. Kumar, U. Bajpai, V. Cheriyath, K. M. Zhang, S. Pillai, H. H. Wortis, and A. L. Roy. 1999. Regulation of nuclear localization and transcriptional activity of TFII-I by Bruton's tyrosine kinase. Mol. Cell. Biol. 19:5014-5024.
30. Parker, R., T. Phan, P. Baumeister, B. Roy, V. Cheriyath, A. L. Roy, and A. S. Lee. 2001. Identification of TFII-I as the endoplasmic reticulum stress response element binding factor ERSF: its autoregulation by stress and interaction with ATF6. Mol. Cell. Biol. 21:3220-3233.
31. Petro, J. B., and W. N. Khan. 2001. Phospholipase C-γ2 couples Bruton's tyrosine kinase to the NF-κB signaling pathway in B lymphocytes. J. Biol. Chem. 276:1715-1719.
32. Rajaiya, J., M. Hatfield, J. C. Nixon, D. J. Rawlings, and C. F. Webb. 2005. Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol. Cell. Biol. 25:2073-2084.
33. Rawlings, D. J., D. C. Saffran, S. Tsukada, D. A. Largaespada, J. C. Grimaldi, L. Cohen, R. N. Mohr, J. F. Bazan, M. Howard, N. G. Copeland, N. A. Jenkins, and O. N. Witte. 1993. Mutation of the unique region of Bruton's tyrosine kinase in immunodeficient XID mice. Science 261:358-361.
34. Roy, A. L. 2001. Biochemistry and biology of the inducible multifunctional transcription factor TFII-I. Gene 274:1-13.
35. Roy, A. L., H. Du, P. D. Gregor, C. D. Novina, E. Martinez, and R. G. Roeder. 1997. Cloning of an Inr- and E-box-binding protein, TFII-I, that interacts physically and functionally with USF1. EMBO J. 16:7091-7104.
36. Roy, A. L., M. Meisterernst, P. Pognonec, and R. G. Roeder. 1991. Cooperative interaction of an initiator-binding transcription initiation factor and the helix-loop-helix activator USF. Nature 354:245-248.
37. Sacristan, C., M. I. Tussie-Luna, S. M. Logan, and A. L. Roy. 2004. Mechanism of Bruton's tyrosine kinase-mediated recruitment and regulation of TFII-I. J. Biol. Chem. 279:7147-7158.
38. Satterthwaite, A. B., and O. N. Witte. 2000. The role of Bruton's tyrosine kinase in B-cell development and function: a genetic perspective. Immunol. Rev. 175:120-127.
39. Tantin, D., M. I. Tussie-Luna, A. L. Roy, and P. A. Sharp. 2004. Regulation of immunoglobulin promoter activity by TFII-I class transcription factors. J. Biol. Chem. 279:5460-5469.
40. Thomas, J. D., P. Sideras, C. I. E. Smith, I. Vorechovsky, V. Chapman, and W. E. Paul. 1993. Colocalization of X-linked agammaglobulinemia and X-linked immunodeficiency genes. Science 261:355-358.
41. Tsukada, S., M. I. Simon, O. N. Witte, and A. Katz. 1994. Binding of beta gamma subunits of heterotrimeric G proteins to the PH domain of Bruton tyrosine kinase. Proc. Natl. Acad. Sci. USA 91:11256-11260.
42. Webb, C. F., C. Das, R. L. Coffman, and P. W. Tucker. 1989. Induction of immunoglobulin μ mRNA in a B cell transfectant stimulated with interleukin-5 and a T-dependent antigen. J. Immunol. 143:3934-3939.
43. Webb, C. F., C. Das, S. Eaton, K. Calame, and P. W. Tucker. 1991. Novel protein-DNA interactions associated with increased immunoglobulin transcription in response to antigen plus interleukin-5. Mol. Cell. Biol. 11:5197-5205.
44. Webb, C. F., Y. Yamashita, N. Ayers, S. Evetts, Y. Paulin, M. E. Conley, and E. A. Smith. 2000. The transcription factor Bright associates with Bruton's tyrosine kinase, the defective protein in immunodeficiency disease. J. Immunol. 165:6956-6965.
45. Yang, W. Y., and S. Desiderio. 1997. BAP-135, a target for Bruton's tyrosine kinase in response to B cell receptor engagement. Proc. Natl. Acad. Sci. USA 94:604-609.